Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€222.60
24.04.23
€263.03
24.04.24
15.03%
25.04.24

Oppenheimer Holdings Inc. 
24.04.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€222.60
24.04.23
€263.03
24.04.24
15.03%
25.04.24

Oppenheimer Holdings Inc. 
24.04.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€222.60
24.04.23
€263.03
24.04.24
15.03%
25.04.24

Oppenheimer Holdings Inc. 
24.04.23 50%
buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.40
24.04.23
€3.63
24.04.24
37.50%
25.04.24

Needham & Company LLC 
24.04.23 50%
buy
Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.40
24.04.23
€6.35
24.04.24
-5.00%
25.04.24

Needham & Company LLC 
24.04.23 50%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.82
23.04.23
-
23.04.24
-60.39%
24.04.24

StockNews.com 
23.04.23 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.21
22.04.23
-
22.04.24
-22.38%
23.04.24

StockNews.com 
22.04.23 50%
sell
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
22.04.23
-
22.04.24
-
23.04.24

StockNews.com 
22.04.23 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€7.95
22.04.23
-
22.04.24
-27.04%
23.04.24

StockNews.com 
22.04.23 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.55
22.04.23
-
22.04.24
-76.33%
23.04.24

StockNews.com 
22.04.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.41
22.04.23
-
22.04.24
-43.90%
23.04.24

StockNews.com 
22.04.23 50%
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.91
22.04.23
-
22.04.24
-52.75%
23.04.24

StockNews.com 
22.04.23 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.40
20.04.23
-
20.04.24
205.00%
21.04.24

Robert W. Baird 
20.04.23 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€101.24
20.04.23
€111.01
20.04.24
-0.75%
21.04.24

JPMorgan Chase & Co. 
20.04.23 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€101.24
20.04.23
€121.02
20.04.24
-0.75%
21.04.24

Sanford C. Bernstein 
20.04.23 50%
sell
Abbott Laboratories

Start price
Target price
Perf. (%)
€101.24
20.04.23
€93.72
20.04.24
-0.75%
21.04.24

Wolfe Research 
20.04.23 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.67
20.04.23
€9.11
20.04.24
-38.50%
21.04.24

Evercore ISI 
20.04.23 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€102.04
20.04.23
€118.42
20.04.24
-1.53%
21.04.24

UBS Group AG 
20.04.23 50%
buy
Innoviva Inc.

Start price
Target price
Perf. (%)
€10.70
20.04.23
€20.50
20.04.24
29.91%
21.04.24

EF Hutton Acquisition Co. I 
20.04.23 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.67
20.04.23
€12.77
20.04.24
-38.50%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€41.00
20.04.23
€54.71
20.04.24
-40.98%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€2.73
20.04.23
€16.39
20.04.24
39.05%
21.04.24

Needham & Company LLC 
20.04.23 50%
buy
AC Immune Ltd

Start price
Target price
Perf. (%)
€2.04
20.04.23
€14.57
20.04.24
15.23%
21.04.24

HC Wainwright 
20.04.23 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
20.04.23
€14.57
20.04.24
-69.78%
21.04.24

HC Wainwright 
20.04.23 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€56.40
20.04.23
€60.11
20.04.24
22.34%
21.04.24

Needham & Company LLC 
20.04.23 50%